LISTAS DEFINITIVAS DE PERSONAS ADMITIDAS Y EXCLUIDAS AL EXAMEN PARA LA OBTENCIÓN DEL CERTIFICADO DE APTITUD PROFESIONAL DE COND
BETH CHACHOUA (ISSY-LES-MOULINEAUX) Chiffre d'affaires, résultat, bilans sur SOCIETE.COM - 491002697
![Plasma MIP-1β levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib - Lung Cancer Plasma MIP-1β levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2d1d2a54-c482-4653-9151-699da0a4ead5/gr1.gif)
Plasma MIP-1β levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib - Lung Cancer
![Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer - Journal of Thoracic Oncology Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2039956535/2053504034/gr1.jpg)
Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer - Journal of Thoracic Oncology
![Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors - Annals of Oncology Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d5524b1f-7071-4ac5-910c-ffc6fab16d7f/gr1_lrg.jpg)